Allion Healthcare Announces Results of Annual Shareholders Meeting

Allion Healthcare (NASDAQ: ALLI) today announced the successful completion of it’s annual meeting held on June 24, 2008 at which three new directors were elected to serve on its six member Board. The shareholders also approved the issuance of 6,125,448 shares of common stock reflecting the one-for-one conversion of Series A-1 Preferred Stock issued as part of the merger consideration for the acquisition of Biomed America, Inc. ("Biomed”). During the meeting, shareholders approved the election of William R. Miller, IV and Kevin D. Stepanuk both of whom were nominated by the former shareholders of Biomed pursuant to certain terms of the Biomed merger. The shareholders also approved the election of William T. Derr who fills the vacancy created by the resignation of Russell J. Fichera to become Allion’s Chief Financial Officer. Messrs. Miller, Stepanuk and Derr all qualify as independent directors and will join Michael P. Moran, Gary P. Carpenter and Harvey Z. Werblowsky, Esq. who also stood for and were approved for re-election at the meeting. "We are very pleased with the outcome of our shareholder meeting,” said Mike Moran, Chairman and Chief Executive Officer of Allion Healthcare. "I would like to thank our shareholders for their support for our new directors and the Biomed transaction. I would also like to thank John Papajohn, Russell J. Fichera and Derrace Schaffer, MD for their dedicated service as past members of the Allion board and look forward to working with Messrs. Miller, Stepanuk and Derr as we execute on our plan to become a leading national provider of specialty pharmacy and disease management services.” About Allion Healthcare Allion Healthcare, Inc. is a national provider of specialty pharmacy and disease management services focused on HIV/AIDS patients as well as specialized biopharmaceutical medications and services to chronically ill patients. Allion Healthcare sells HIV/AIDS medications, ancillary drugs and nutritional supplies under the trade name MOMS Pharmacy. Allion Healthcare provides services for the intravenous immunoglobulin, Blood Clotting Factor and other therapies through its Biomed division. Allion Healthcare works closely with physicians, nurses, clinics, AIDS Service Organizations, and with government and private payors to improve clinical outcomes and reduce treatment costs.